Pharmacokinetic and Safety Study of MRX-2843 in Adults With Relapsed/Refractory Advanced and/or Metastatic Solid Tumors
Meryx, Inc.
Meryx, Inc.
Corcept Therapeutics
University of Aarhus
Pfizer
Celgene
Yale University
University of Kansas Medical Center
BBB-Therapeutics B.V.
AVEO Pharmaceuticals, Inc.
Tracon Pharmaceuticals Inc.